GB9404378D0 - Quinoline derivatives - Google Patents

Quinoline derivatives

Info

Publication number
GB9404378D0
GB9404378D0 GB9404378A GB9404378A GB9404378D0 GB 9404378 D0 GB9404378 D0 GB 9404378D0 GB 9404378 A GB9404378 A GB 9404378A GB 9404378 A GB9404378 A GB 9404378A GB 9404378 D0 GB9404378 D0 GB 9404378D0
Authority
GB
United Kingdom
Prior art keywords
quinoline derivatives
quinoline
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9404378A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to GB9404378A priority Critical patent/GB9404378D0/en
Publication of GB9404378D0 publication Critical patent/GB9404378D0/en
Priority to CA002214521A priority patent/CA2214521A1/en
Priority to PCT/JP1995/000263 priority patent/WO1995024395A1/en
Priority to AU18235/95A priority patent/AU1823595A/en
Priority to JP7523351A priority patent/JPH09509957A/en
Priority to TW084102060A priority patent/TW350838B/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
GB9404378A 1994-03-07 1994-03-07 Quinoline derivatives Pending GB9404378D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB9404378A GB9404378D0 (en) 1994-03-07 1994-03-07 Quinoline derivatives
CA002214521A CA2214521A1 (en) 1994-03-07 1995-02-22 Quinoline derivatives as immunomodulators
PCT/JP1995/000263 WO1995024395A1 (en) 1994-03-07 1995-02-22 Quinoline derivatives as immunomodulators
AU18235/95A AU1823595A (en) 1994-03-07 1995-02-22 Quinoline derivatives as immunomodulators
JP7523351A JPH09509957A (en) 1994-03-07 1995-02-22 Quinoline derivatives as immunomodulators
TW084102060A TW350838B (en) 1994-03-07 1995-03-04 Quinoline derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9404378A GB9404378D0 (en) 1994-03-07 1994-03-07 Quinoline derivatives

Publications (1)

Publication Number Publication Date
GB9404378D0 true GB9404378D0 (en) 1994-04-20

Family

ID=10751426

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9404378A Pending GB9404378D0 (en) 1994-03-07 1994-03-07 Quinoline derivatives

Country Status (6)

Country Link
JP (1) JPH09509957A (en)
AU (1) AU1823595A (en)
CA (1) CA2214521A1 (en)
GB (1) GB9404378D0 (en)
TW (1) TW350838B (en)
WO (1) WO1995024395A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0100407A3 (en) * 1997-12-15 2002-01-28 Fujisawa Pharmaceutical Co Process for producing quinoline carbamoyl and thio carbamoyl derivatives and intermediates
SE9802550D0 (en) * 1998-07-15 1998-07-15 Active Biotech Ab Quinoline derivatives
US6133285A (en) 1998-07-15 2000-10-17 Active Biotech Ab Quinoline derivatives
US6121287A (en) * 1998-07-15 2000-09-19 Active Biotech Ab Quinoline derivatives
SE9802549D0 (en) * 1998-07-15 1998-07-15 Active Biotech Ab Quinoline derivatives
SE0002320D0 (en) * 1999-10-25 2000-06-21 Active Biotech Ab Malignant tumors
US6395750B1 (en) 1999-10-25 2002-05-28 Active Biotech Ab Drugs for the treatment of malignant tumors
TWI250023B (en) * 2001-10-22 2006-03-01 Santen Pharmaceutical Co Ltd Pharmaceutical composition for itch treating agent
JP2007191495A (en) * 2001-10-22 2007-08-02 Santen Pharmaceut Co Ltd Pruritus treating agent
AUPS058102A0 (en) 2002-02-15 2002-03-14 Fujisawa Pharmaceutical Co., Ltd. Imidazole compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52670B1 (en) * 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
SE8902076D0 (en) * 1989-06-09 1989-06-09 Pharmacia Ab DERIVATIVES OF QUINOLINE-3-CARBOXANILIDE
GB9108547D0 (en) * 1991-04-22 1991-06-05 Fujisawa Pharmaceutical Co Quinoline derivatives
TW222276B (en) * 1992-01-27 1994-04-11 Fujisawa Pharmaceutical Co
GB9311562D0 (en) * 1993-06-04 1993-07-21 Fujisawa Pharmaceutical Co Heterocyclic derivatives

Also Published As

Publication number Publication date
CA2214521A1 (en) 1995-09-14
AU1823595A (en) 1995-09-25
JPH09509957A (en) 1997-10-07
TW350838B (en) 1999-01-21
WO1995024395A1 (en) 1995-09-14

Similar Documents

Publication Publication Date Title
IL113844A0 (en) Quinoline derivatives
IL124522A0 (en) Quinoline derivatives
ZA952413B (en) 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
GB9511077D0 (en) 17B-Substituted-6-azasteroid derivatives
EP0708091A3 (en) Indoloylguanidine derivatives
ZA977326B (en) Tetrahydroquinoline derivatives
ZA953356B (en) Benzocycloalkylazolethione derivatives
EP0747348A4 (en) Aminoalkylcyclopropane derivative
EP0692482A3 (en) 1-pyridyltetrazolinone derivatives
GB2295614B (en) Novel 5-pyrrolyl-6-halogeno-2-pyridylmethylsulfinylbenzimidazole derivatives
IL112519A0 (en) 5-heteroarylindole derivatives
ZA954125B (en) Novel dialkoxy-pyridinyl-benzimidazole derivatives
GB9404378D0 (en) Quinoline derivatives
HU9503339D0 (en) Amino-cyclopentane derivative
ZA954269B (en) Quinoline derivatives
GB9402275D0 (en) Quinoline derivatives
GB9511365D0 (en) Pyridazino-indole derivatives
HU9503582D0 (en) Thienopyridon derivatives
GB9413150D0 (en) Quinoline derivatives
EG24161A (en) Carbostyril derivatives
AU3578495A (en) Quinoline derivative
GB9413937D0 (en) Quinoline derivatives
IL139301A0 (en) Quinoline derivatives
GB9402306D0 (en) Quinoline derivatives
GB2291425B (en) 7-Diazo-beta-lactam derivatives